Moreover, we previously reported that treatment with a neutralizing antibody against soluble forms of ephrin-A1 inhibited primary tumor growth [19], and another group reported that soluble ephrin-A1 induced cell proliferation in some human breast cancer cell lines [31]. This evidence concerns the gene EFNA1 and breast carcinoma.